Making Medicines in Europe
Creating a more resilient and integrated European pharmaceutical landscape, for the benefit of patients and the broader healthcare ecosystem

We are all in for Europe's better health
Teva’s 2024-2029 vision of what’s next in Europe for patients, science, people and society

Teva consumer research on manufacturing resilience
Dive into the research to better understand what patients expect from pharmaceutical companies and governments regarding supply and manufacturing of medicines.

Infographic: The case for change in Europe
Insights from 3,000 European patients offered perspectives on medicine supply and manufacturing | May 2021

Pharmaceutical Manufacturing Resilience in Europe
Strategic dialogue between government and industry partners supports a healthy manufacturing network | July 2020
This information is intended for a European audience.